6-MAPDB

6-MAPDB (6-Methyl-amino-propyl-benzofuran-dibromide) is a psychoactive drug and research chemical that is structurally related to MDMA (3,4-Methylenedioxymethamphetamine) and 6-APDB (6-Aminopropyl-benzofuran-dibromide). It is known for its entactogenic effects, which are similar to those of MDMA, but it is less potent and has a longer duration of action.

Chemistry

6-MAPDB is a benzofuran derivative, which is a type of organic compound that contains a benzene ring fused to a furan ring. The molecule also contains a methyl group attached to the amino group, and a propyl group attached to the benzofuran ring. The presence of these groups gives 6-MAPDB its unique chemical properties and distinguishes it from other benzofuran derivatives.

Pharmacology

The pharmacology of 6-MAPDB is not fully understood, but it is believed to act as a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI), similar to MDMA. This means that it increases the levels of these neurotransmitters in the brain by preventing their reuptake into neurons. This leads to increased neuronal activity and produces the drug's psychoactive effects.

Effects

The effects of 6-MAPDB are similar to those of MDMA and include feelings of euphoria, increased empathy, and heightened sensory perception. However, the drug is less potent than MDMA and its effects last longer. Some users also report experiencing visual hallucinations.

Legal Status

The legal status of 6-MAPDB varies by country. In some countries, it is classified as a controlled substance, while in others it is legal to possess for personal use.

See Also

• MDMA
• 6-APDB
• Benzofuran
• Psychoactive drug
• Research chemical